{
    "Trade/Device Name(s)": [
        "Spectral West Nile Virus IgM STATusTM Test",
        "Spectral WNV IgM STATusTM test"
    ],
    "Submitter Information": "Spectral Diagnostics Inc.",
    "510(k) Number": "K052519",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031952"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NOP"
    ],
    "Summary Letter Date": "November 10, 2006",
    "Summary Letter Received Date": "November 14, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3940"
    ],
    "Regulation Name(s)": [
        "West Nile Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "serology"
    ],
    "Analyte(s)": [
        "IgM antibodies to West Nile Virus"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Sodium heparin tube",
        "Sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic lateral flow assay"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for Spectral West Nile Virus IgM STATusTM rapid immunochromatographic test for qualitative detection of IgM antibodies to West Nile Virus in serum or plasma.",
    "Indications for Use Summary": "For presumptive laboratory diagnosis of West Nile virus infection in patients with signs and symptoms of meningoencephalitis, detecting IgM antibodies to WNV in human serum or plasma; not for point of care, home use, or donor screening.",
    "fda_folder": "Microbiology"
}